BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20109218)

  • 1. Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas.
    Stall B; Zach L; Ning H; Ondos J; Arora B; Shankavaram U; Miller RW; Citrin D; Camphausen K
    Radiat Oncol; 2010 Jan; 5():5. PubMed ID: 20109218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target definition for malignant gliomas: no difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging.
    Guarnaschelli JN; Vagal AS; McKenzie JT; McPherson CM; Warnick RE; Batra V; Breneman JC; Lamba MA
    Pract Radiat Oncol; 2014; 4(5):e195-e201. PubMed ID: 25194105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FET-PET for malignant glioma treatment planning.
    Niyazi M; Geisler J; Siefert A; Schwarz SB; Ganswindt U; Garny S; Schnell O; Suchorska B; Kreth FW; Tonn JC; Bartenstein P; la Fougère C; Belka C
    Radiother Oncol; 2011 Apr; 99(1):44-8. PubMed ID: 21458093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-fusion of MR spectroscopic images for treatment planning of gliomas.
    Chang J; Thakur S; Perera G; Kowalski A; Huang W; Karimi S; Hunt M; Koutcher J; Fuks Z; Amols H; Narayana A
    Med Phys; 2006 Jan; 33(1):32-40. PubMed ID: 16485406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion magnetic resonance imaging in contouring of glioblastoma patients: Preliminary experience from a single institution.
    Munshi A; Ganesh T; Gupta RK; Vaishya S; Patir R; Sarkar B; Khataniar N; Bansal K; Rastogi K; Mohanti BK
    J Cancer Res Ther; 2020; 16(6):1488-1494. PubMed ID: 33342818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.
    Jaymanne DT; Kaushal S; Chan D; Schembri G; Brazier D; Bailey D; Wheeler H; Back M
    J Med Imaging Radiat Oncol; 2018 Feb; 62(1):122-127. PubMed ID: 28980392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
    Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies.
    Tsien C; Gomez-Hassan D; Ten Haken RK; Tatro D; Junck L; Chenevert TL; Lawrence T
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):328-32. PubMed ID: 15890571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Lumpectomy Cavity Delineations Between Use of Magnetic Resonance Imaging and Computed Tomography Acquired With Patient in Prone Position for Radiation Therapy Planning of Breast Cancer.
    Huang W; Currey A; Chen X; Li B; Bergom C; Kelly T; Wilson JF; Li XA
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):832-40. PubMed ID: 26972656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas.
    Grosu AL; Weber W; Feldmann HJ; Wuttke B; Bartenstein P; Gross MW; Lumenta C; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):517-26. PubMed ID: 10802381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any additional benefit of
    Şahin M; Akgun E; Sirolu S; Can G; Sayman HB; Oner Dincbas F
    Br J Radiol; 2022 Oct; 95(1139):20220049. PubMed ID: 35993417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study.
    Wang B; Liu Y; Zhang J; Yin S; Liu B; Ding S; Qiu B; Deng X
    J Neurooncol; 2024 Mar; 167(1):123-132. PubMed ID: 38300388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas.
    Champ CE; Siglin J; Mishra MV; Shen X; Werner-Wasik M; Andrews DW; Mayekar SU; Liu H; Shi W
    Radiat Oncol; 2012 Dec; 7():220. PubMed ID: 23259933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
    Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Value of Intraoperative and Early Postoperative Magnetic Resonance Imaging in Low-Grade Glioma Surgery: A Retrospective Study.
    Pala A; Brand C; Kapapa T; Hlavac M; König R; Schmitz B; Wirtz CR; Coburger J
    World Neurosurg; 2016 Sep; 93():191-7. PubMed ID: 27288582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical target volume delineation in glioblastomas: pre-operative versus post-operative/pre-radiotherapy MRI.
    Farace P; Giri MG; Meliadò G; Amelio D; Widesott L; Ricciardi GK; Dall'Oglio S; Rizzotti A; Sbarbati A; Beltramello A; Maluta S; Amichetti M
    Br J Radiol; 2011 Mar; 84(999):271-8. PubMed ID: 21045069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma.
    Back M; LeMottee M; Crasta C; Bailey D; Wheeler H; Guo L; Eade T
    Radiat Oncol; 2017 Mar; 12(1):46. PubMed ID: 28253929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy.
    Nakamatsu K; Suzuki M; Nishimura Y; Kanamori S; Koike R; Shibata T; Shintani N; Okumura M; Okajima K; Akai F
    Int J Clin Oncol; 2008 Feb; 13(1):48-53. PubMed ID: 18307019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.